Advanced in Relapsing Polychondritis

Dr. Howard Kenney

Rheumatology
Providence
105 West 8th Avenue, Suite 6080W, 
Spokane, WA 
Offers Telehealth
48 Years of Experience
Advanced in Relapsing Polychondritis
Providence
105 West 8th Avenue, Suite 6080W, 
Spokane, WA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Howard Kenney is a Rheumatologist in Spokane, Washington. Dr. Kenney has been practicing medicine for over 48 years and is rated as an Advanced provider by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Rheumatoid Arthritis (RA), Synovitis, Psoriatic Arthritis, Orchiectomy, and Craniectomy.

His clinical research consists of co-authoring 36 peer reviewed articles and participating in 9 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Specialist in WA
Hospital Affiliations
Kootenai Health
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Community Health
  • EPO
  • HMO
Coordinated Care
  • HMO
  • MANAGED MEDICAID PLAN
Group Health Cooperative
  • HMO
  • POS
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
HMSA
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
Lifewise

Accepted plan types not found. Please verify directly with the provider.

Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera
  • EPO
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 22 Less Insurance Carriers -

Locations

105 West 8th Avenue, Suite 6080W, Spokane, WA 99204
Call: 509-838-6500

Additional Areas of Focus

Dr. Kenney has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Hypoparathyroidism

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Vectra InVolved Informed Decision Outcome Study (VIVID): A Prospective Randomized Controlled Trial Evaluating the Effect of Guided Care With Vectra Compared to Treatment as Usual in Patients With Rheumatoid Arthritis
Enrollment Status: Active_not_recruiting
Publish Date: November 06, 2025
Intervention Type: Diagnostic test
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
A Phase 4, Open-Label, Multicenter, Efficacy, Safety, Pharmacokinetics and Pharmacodynamics Trial of Intravenous KRYSTEXXA® (Pegloticase) Administered Every 4 Weeks With Co-Administration of Weekly Doses of Methotrexate in Patients With Uncontrolled Refractory Gout (FORWARD Open-Label [OL] Trial)
Enrollment Status: Completed
Publish Date: October 01, 2025
Intervention Type: Biological, Drug
Study Drugs: Pegloticase, Methotrexate
Study Phase: Phase 4
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Vagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA Study
Enrollment Status: Active_not_recruiting
Publish Date: August 13, 2025
Intervention Type: Procedure, Device, Drug
Study Drug: Conventional Synthetic DMARD
Study Phase: Phase 3
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 2 Pilot Study Evaluating Intravenous Iloprost in Subjects With Symptomatic Raynaud's Phenomenon Secondary to Systemic Sclerosis
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study Evaluating the Safety and Efficacy of Intravenous Iloprost in Subjects With Systemic Sclerosis Experiencing Symptomatic Digital Ischemic Episodes (AURORA Study)
Enrollment Status: Completed
Publish Date: May 25, 2025
Intervention Type: Drug
Study Drug: Iloprost
Study Phase: Phase 3
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
A Multicenter, Efficacy and Safety Study of Methotrexate to Increase Response Rates in Patients With Uncontrolled Gout Receiving KRYSTEXXA® (Pegloticase) (MIRROR Open-Label [OL])
Enrollment Status: Completed
Publish Date: June 26, 2024
Intervention Type: Biological, Drug, Dietary supplement
Study Phase: Phase 4
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
A Phase 1b Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of TAK-079 in Combination With Standard Background Therapy in Patients With Moderate to Severe Systemic Lupus Erythematosus
Enrollment Status: Completed
Publish Date: March 29, 2024
Intervention Type: Drug
Study Drug: TAK-079
Study Phase: Phase 1
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
A Multicenter, Open-Label, Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis
Enrollment Status: Completed
Publish Date: October 12, 2023
Intervention Type: Drug
Study Drugs: Olokizumab, Methotrexate
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

36 Total Publications

Automated Joint Space Detection Improves Bone Segmentation Accuracy.
Automated Joint Space Detection Improves Bone Segmentation Accuracy.
Journal: Journal of visualized experiments : JoVE
Published: December 15, 2025
View All 36 Publications
Similar Doctors
Experienced in Relapsing Polychondritis
Dr. Dustin D. Dinning
Rheumatology
Experienced in Relapsing Polychondritis
Dr. Dustin D. Dinning
Rheumatology

Beacon Cancer Care PLLC

3815 N Schreiber Way, Unit 101, 
Coeur D Alene, ID 
 (30.2 miles away)
208-755-2804
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dustin Dinning is a Rheumatologist in Coeur D Alene, Idaho. Dr. Dinning is rated as a Distinguished provider by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Psoriatic Arthritis, Rheumatoid Arthritis (RA), Psoriasis, and Polymyalgia Rheumatica. Dr. Dinning is currently accepting new patients.

Experienced in Relapsing Polychondritis
Dr. Michael C. Coan
Rheumatology
Experienced in Relapsing Polychondritis
Dr. Michael C. Coan
Rheumatology

Arthritis Northwest PLLC

105 W 8th Ave, Suite 6080, 
Spokane, WA 
 (0.7 miles away)
509-838-6500
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Coan is a Rheumatologist in Spokane, Washington. Dr. Coan is rated as a Distinguished provider by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Rheumatoid Arthritis (RA), Ankylosing Spondylitis, Axial Spondyloarthritis (AxSpA), and Rheumatoid Pneumoconiosis. Dr. Coan is currently accepting new patients.

Experienced in Relapsing Polychondritis
Dr. Christopher C. Wright
Rheumatology
Experienced in Relapsing Polychondritis
Dr. Christopher C. Wright
Rheumatology

Arthritis Northwest PLLC

105 W 8th Ave, Suite 6080, 
Spokane, WA 
 (0.7 miles away)
509-838-6500
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Christopher Wright is a Rheumatologist in Spokane, Washington. Dr. Wright is rated as a Distinguished provider by MediFind in the treatment of Relapsing Polychondritis. His top areas of expertise are Psoriatic Arthritis, Psoriasis, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Wright is currently accepting new patients.

VIEW MORE RELAPSING POLYCHONDRITIS DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kenney's expertise for a condition
ConditionClose
    • Distinguished
    • Calcium Pyrophosphate Arthritis
      Dr. Kenney is
      Distinguished
      . Learn about Calcium Pyrophosphate Arthritis.
      See more Calcium Pyrophosphate Arthritis experts
    • Fibromyalgia
      Dr. Kenney is
      Distinguished
      . Learn about Fibromyalgia.
      See more Fibromyalgia experts
    • MASS Phenotype
      Dr. Kenney is
      Distinguished
      . Learn about MASS Phenotype.
      See more MASS Phenotype experts
    • Mixed Connective Tissue Disease
      Dr. Kenney is
      Distinguished
      . Learn about Mixed Connective Tissue Disease.
      See more Mixed Connective Tissue Disease experts
    • Psoriasis
      Dr. Kenney is
      Distinguished
      . Learn about Psoriasis.
      See more Psoriasis experts
    • Psoriatic Arthritis
      Dr. Kenney is
      Distinguished
      . Learn about Psoriatic Arthritis.
      See more Psoriatic Arthritis experts
    View All 9 Distinguished Conditions
    • Advanced
    • Ankylosing Spondylitis
      Dr. Kenney is
      Advanced
      . Learn about Ankylosing Spondylitis.
      See more Ankylosing Spondylitis experts
    • Arthritis
      Dr. Kenney is
      Advanced
      . Learn about Arthritis.
      See more Arthritis experts
    • Axial Spondyloarthritis (AxSpA)
      Dr. Kenney is
      Advanced
      . Learn about Axial Spondyloarthritis (AxSpA).
      See more Axial Spondyloarthritis (AxSpA) experts
    • Behcet Disease
      Dr. Kenney is
      Advanced
      . Learn about Behcet Disease.
      See more Behcet Disease experts
    • Bursitis
      Dr. Kenney is
      Advanced
      . Learn about Bursitis.
      See more Bursitis experts
    • Cervical Myelopathy
      Dr. Kenney is
      Advanced
      . Learn about Cervical Myelopathy.
      See more Cervical Myelopathy experts
    View All 28 Advanced Conditions
    • Experienced
    • Adult Still's Disease
      Dr. Kenney is
      Experienced
      . Learn about Adult Still's Disease.
      See more Adult Still's Disease experts
    • Cicatricial Pemphigoid
      Dr. Kenney is
      Experienced
      . Learn about Cicatricial Pemphigoid.
      See more Cicatricial Pemphigoid experts
    • Craniectomy
      Dr. Kenney is
      Experienced
      . Learn about Craniectomy.
      See more Craniectomy experts
    • Cryoglobulinemia
      Dr. Kenney is
      Experienced
      . Learn about Cryoglobulinemia.
      See more Cryoglobulinemia experts
    • Cutaneous Lupus Erythematosus (CLE)
      Dr. Kenney is
      Experienced
      . Learn about Cutaneous Lupus Erythematosus (CLE).
      See more Cutaneous Lupus Erythematosus (CLE) experts
    • Dermatomyositis
      Dr. Kenney is
      Experienced
      . Learn about Dermatomyositis.
      See more Dermatomyositis experts
    View All 42 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment